Huadong Medicine Co., Ltd
000963
Classifica tra le azioni
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Prezzo delle azioni
$3.89
Capitalizzazione di mercato
$6.83B
Variazione (1 giorno)
-2.22%
Variazione (1 anno)
-30.58%
Paese
CN
Scambia Huadong Medicine Co., Ltd (000963)
Categoria
Healthcare
Rapporto P/S per Huadong Medicine Co., Ltd (000963)
Rapporto P/S al October 2026 TTM: 1.04
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Huadong Medicine Co., Ltd, il rapporto P/S attuale (TTM) è 1.04. Alla fine del 2024, era pari a 1.45.
Storico del rapporto P/S per Huadong Medicine Co., Ltd da 2001 a 2026
Rapporto P/S alla fine di ogni anno
| Anno | Rapporto P/S | Cambia |
|---|---|---|
| 2026 (TTM) | 1.04 | -34.83% |
| 2025 | 1.59 | 9.57% |
| 2024 | 1.45 | -19.08% |
| 2023 | 1.79 | -17.67% |
| 2022 | 2.17 | 6.69% |
| 2021 | 2.04 | 47.50% |
| 2020 | 1.38 | 14.65% |
| 2019 | 1.20 | 5.83% |
| 2018 | 1.14 | -39.88% |
| 2017 | 1.89 | 38.15% |
| 2016 | 1.37 | -16.29% |
| 2015 | 1.64 | 35.51% |
| 2014 | 1.21 | 0.71% |
| 2013 | 1.20 | 18.17% |
| 2012 | 1.01 | -2.10% |
| 2011 | 1.04 | -34.93% |
| 2010 | 1.59 | 55.30% |
| 2009 | 1.03 | 32.57% |
| 2008 | 0.77 | -50.74% |
| 2007 | 1.57 | 227.06% |
| 2006 | 0.48 | 27.11% |
| 2005 | 0.38 | -21.59% |
| 2004 | 0.48 | -19.33% |
| 2003 | 0.60 | -11.17% |
| 2002 | 0.67 | -8.68% |
| 2001 | 0.74 | 0.00% |
Rapporto P/S per aziende simili o concorrenti
| Azienda | Rapporto P/S | Differenza del rapporto P/S | Il paese |
|---|---|---|---|
| 2.82 | 171.75% |
DE
|
|
| 3.02 | 191.24% |
DE
|
|
| 2.19 | 111.04% |
JP
|
|
| 8.92 | 760.91% |
CH
|
|
| 7.04 | 579.46% |
IN
|
